Science Explorer Interactive view Map
Company · Champaign · United States

Vanquish Oncology (United States)

Research works
3
▲ 51% vs 2013–17
Citations
11
3.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
26%
world 28%

Not ranked overall: Vanquish Oncology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Vanquish Oncology (United States) publish most on?

By volume in 2022–2025: Neuroendocrine Tumor Research Advances, Protein Kinase Regulation and GTPase Signaling, Cell death mechanisms and regulation and Glioma Diagnosis and Treatment.

  1. 1 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  2. 2 Protein Kinase Regulation and GTPase Signaling Molecular Biology 0 works
  3. 3 Cell death mechanisms and regulation Molecular Biology 0 works
  4. 4 Glioma Diagnosis and Treatment Genetics 0 works
  5. 5 PARP inhibition in cancer therapy Oncology 0 works
  6. 6 Ocular Oncology and Treatments Ophthalmology 0 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 0 works
  8. 8 Cancer-related Molecular Pathways Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.3%not open73.7%

World: 28% of research is openly available.

with international co-authors5.1%domestic only94.9%

World: 19% is written across borders.

How has Vanquish Oncology (United States)'s research output changed?

Output in 2018–2022 was 51% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Champaign

All research institutions in Champaign

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.